Suggestions
Anne Katrin Schlag
Acting Chief Executive Officer
Anne Katrin Schlag is the Acting Chief Executive Officer at Drug Science, a UK-based organization focused on research and advocacy related to drug policy and medical cannabis. She has a background as a Chartered Psychologist and previously served as the Head of Research at Drug Science, where she led initiatives such as Project Twenty21, aimed at expanding access to medical cannabis through real-world evidence.4
In her role, Schlag emphasizes the importance of ethical frameworks in developing psychedelic-assisted therapies and advocates for changes in UK drug laws, particularly concerning psychedelics and cannabis.35 Her professional network includes over 500 connections on LinkedIn, indicating her active engagement in the field.1
Schlag's contributions extend beyond administration; she actively participates in discussions about the value of real-world evidence in medical cannabis applications, showcasing her commitment to evidence-based approaches in drug policy reform.2
